Sign Up to like & get
recommendations!
1
Published in 2020 at "NPJ Breast Cancer"
DOI: 10.1038/s41523-020-00186-5
Abstract: This study aimed to investigate the prognostic value of biological factors, including histological grade, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) status in de novo stage IV breast cancer.…
read more here.
Keywords:
novo stage;
stage;
stage breast;
breast cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of cutaneous pathology"
DOI: 10.1111/cup.70013
Abstract: A 66-year-old female presented with seven months of progressive right upper eyelid (RUL) drooping and thickening of her right lower eyelid (RLL). MRI revealed soft tissue enhancement of the RUL and RLL pre-septal planes without…
read more here.
Keywords:
breast;
novo stage;
initial presentation;
carcinoma ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs23-po2-06-05
Abstract: [Background] Although several prospective randomized trials have not shown a statistically significant difference in overall survival(OS),and quality-of-life(QOL) for the primary tumor surgery(PTS) of De novo stageⅣ breast cancer(BC), but more recent studies showed that could…
read more here.
Keywords:
surgery;
breast cancer;
novo stage;
stage ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.1082
Abstract: 1082Background: Current guidelines lack definitive evidences about the relative benefits of locoregional surgery for the primary tumor in de novo stage IV breast cancer. The aim of this study was to comprehensively investigate the role…
read more here.
Keywords:
surgery;
locoregional surgery;
primary tumor;
novo stage ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.1022
Abstract: 1022 Background: Genomic profiling of primary and recurrent metastatic breast cancer (rMBC) has revealed potential resistance mechanisms to therapy. In contrast, de novo stage IV breast cancer (DNIV) represents an opportunity to elucidate metastatic drivers…
read more here.
Keywords:
mut;
breast cancer;
dniv;
novo stage ... See more keywords